Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Urinary Bladder Neoplasms 1Surgery 1Stress, Psychological 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Ductal Adenocarcinoma 1Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer 1Multiple Myeloma 1Medulloblastoma 1Lung Neoplasms 1Liposarcoma 1Leiomyosarcoma 1Intermittent Fasting 1Head and Neck Neoplasms 1HER2-positive Breast Cancer 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1Breast Cancer Invasive 1

Interventions

pertuzumab 3Trastuzumab 3Docetaxel 2tucatinib 1atezolizumab 1Paclitaxel 1Neoadjuvant Therapy 1Genetic Testing 1Capecitabine 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HER2-positive Breast Cancer × Neoadjuvant Therapy × 30 days × Clear all
NCT07616440 2026-06-04

Pilot Study on the Clinical Efficacy of Focused Ultrasound-Mediated Targeted Drug Delivery System Combined With Neoadjuvant Therapy for HER2-Positive Breast Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Recruiting
20 enrolled
Breast

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡